Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, ... (206.272.4434 E: invest@ctiseattle.co...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)

Date:9/23/2007

206.272.4434

E: invest@ctiseattle.com

http://www.cticseattle.com/investors.htm

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Leadership insights from co-founder of Yesmail
2. John Bergman, co-founder of Guild Software
3. At Berbee, president replaces founder as CEO
4. Online Kiosks founder Mike Strand uses contest to screen new business plan
5. Third Wave co-founder shoots for small target in latest project
6. Entrepreneurial Profile: Kelly Henrickson, founder of Prodesse, Inc.
7. Strandware Founder Establishes Consulting Firm
8. Epics Founder Judy Faulkner Speaks on Culture, Business Beliefs, and Recruiting: WTN Exclusive Coverage
9. Interview: Billpoint Founder Jason May on eBay, Open Source
10. WTN Interview: Alex Bratton: EmailRXs founder on viruses and spam
11. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications

Post Your Comments:

Breaking Biology Technology:RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6 Vivakor Confirms Record Date of Stock Dividend 2 Vivakor Confirms Record Date of Stock Dividend 3 Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2 JourneyLite of Houston Now Offering Sleeve Gastrectomy 2

[0] RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE)[0] Vivakor Confirms Record Date of Stock Dividend [0] Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)[0] JourneyLite of Houston Now Offering Sleeve Gastrectomy

Other Biology Technology:AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1 2 Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes 2 Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes 3 Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes 4 Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes 5 ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imaging 2

AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1 Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imaging

Breaking Biology News(10 mins):Delivering medicine directly into a tumor 2 Biogen Idec's oral compound BG-12 achieves development milestones in MS and RA 2 Drug for erectile dysfunction improves heart function in young heart disease patients 61624 1 Kill the cancer not the patient 3A New toxicity testing approach could make chemo drugs safer 10789 1 Kill the cancer not the patient 3A New toxicity testing approach could make chemo drugs safer 10789 2 IWillAgain com Launches Online Community for Athletes Overcoming Accident Illness or Injury 61623 1 IWillAgain com Launches Online Community for Athletes Overcoming Accident Illness or Injury 61623 2

[0] Delivering medicine directly into a tumor [0] Biogen Idec's oral compound BG-12 achieves development milestones in MS and RA [0] Tiny RNA has big impact on lung cancer tumors

Other Biology News:UF researchers devise way to calculate rates of evolution 2 UF researchers devise way to calculate rates of evolution 3 Simons Foundation awards Emory scientists $3M for autism gene research 2 Bilberry extract -- can it help prevent certain cancers? 2 Bilberry extract -- can it help prevent certain cancers? 3

UF researchers devise way to calculate rates of evolution Simons Foundation awards Emory scientists $3M for autism gene research Bilberry extract -- can it help prevent certain cancers?

Biology Products:

FLA-5000 Imaging System from FUJIFILM Life Science T1 Thermocylcer 384 from LABREPCO, Inc.SDSOUT SDS PRECIPITATION from Pierce Biotechnology, Inc.Agencourt SPRPlate D - Disc Magnet Plate from Agencourt Bioscience